Evidence map›Paper›PMID 34963505›Full record

ArticleEmerging infectious diseases2022

Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.

Vanessa C Nicolete, Priscila T Rodrigues, Anderson R J Fernandes, Rodrigo M Corder, Juliana Tonini, Lewis F Buss, Flávia C Sales, Nuno R Faria, Ester C Sabino, Marcia C Castro and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Resolving the enigma of Iquitos and Manaus: A modeling analysis of multiple COVID-19 epidemic waves in two Amazonian cities.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Pediatric COVID-19: clinical and epidemiological data of 1303 cases in a general hospital in Brazil.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Vanessa C Nicolete
Priscila T Rodrigues
Anderson R J Fernandes
Rodrigo M Corder
Juliana Tonini
Lewis F Buss
Flávia C Sales
Nuno R Faria
Ester C Sabino
Marcia C Castro
Marcelo U Ferreira
Universidade de São Paulo · BRHarvard University · USImperial College London · GBUniversity of Oxford · GB

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2010 to 2023
$20.1M
Medical Research Council MR/R015600/1Medical Research Council MR/S019510/1NIAID NIH HHS U19 AI089681
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Gamma variant has been hypothesized to cause more severe illness than previous variants, especially in children. Successive SARS-CoV-2 IgG serosurveys in the Brazilian Amazon showed that age-specific attack rates and proportions of symptomatic SARS-CoV-2 infections were similar before and after Gamma variant emergence.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralBrazilChildHumansAntibodies, Viral2019 novel coronavirus diseaseAmazonBrazilcoronavirus diseaseCOVID-19Gamma variantrespiratory infectionsSARS-CoV-2seroprevalencesevere acute respiratory syndrome coronavirus 2viruseszoonoses

Identifiers

PMID34963505
PMCPMC8888227
OpenAlexW4200048811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.